Arena Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 89   

Articles published

ARNA 1.71 +0.04 (2.40%)
price chart
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) added about 5.1 percent in value ...
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) is expected to announce second quarter financial results estimated on August 03, 2016.
The Insider Activity Don't Lie: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)  Review Fortune
Review Analyst's saying: AbbVie Inc. (NYSE:ABBV) , Arena Pharmaceuticals ...  Is stories
Biotech Stocks Worth Chasing: Celgene Corp. (CELG), Arena Pharmaceuticals, Inc ...
Arena Pharmaceuticals, Inc. (ARNA) recently recorded 0.6 percent change and currently at $1.67 is 28.46 percent away from its 52-week low and down -59.95 percent versus its peak.
Scorching Hot Biotech Stocks Tape: Zafgen, Inc. (ZFGN), Arena Pharmaceuticals ...
Arena Pharmaceuticals, Inc. (ARNA) recently recorded -5.62 percent change and currently at $1.68 is 29.23 percent away from its 52-week low and down -61.02 percent versus its peak.
Arena Pharma stock rises 8.8% after weight-loss drug is approved
Arena Pharmaceuticals Inc. ARNA, -5.62% shares rose 8.8% in pre-market trade Tuesday after the company said its weight-loss drug with Eisai Inc. 4523, +0.46% received Food and Drug Administration approval.
Eisai Inc. and Arena Pharmaceuticals Announce FDA Approval of BELVIQ XR ...
WOODCLIFF LAKE, N.J. and SAN DIEGO, July 19, 2016 /PRNewswire/ -- Eisai Inc. and Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today announced that the U.S.
Arena - Belviq Scripts Start Q3 In Tough Shape  Seeking Alpha
Analyst's PT Viewpoints: Eli Lilly and Company (NYSE:LLY) , Arena ...
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) closed with decline of -1.19% to $1.66. Recent traded volume was 719.69 thousand shares versus to it an average volume of 1.82 million shares.
Arena Pharmaceuticals Inc Stock Technicals at Critical Inflection Point
This is a technical analysis stock rating for Arena Pharmaceuticals Inc (NASDAQ:ARNA) . The company has a three bull technical rating which indicates an inflection point.
Two Stocks within Analysts Review: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA ...
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) diminished -5.62%, closing at $1.68 after floating between $1.68 and $1.79.
Latest Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Target Price Suggests Stock ...  Review Fortune
Best known Analyst's Ratings: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA ...  Is stories
Arena Pharmaceuticals Inc. (ARNA) Shares Bought by Wellington Management Group LLP
Arena Pharmaceuticals logo Wellington Management Group LLP raised its position in shares of Arena Pharmaceuticals Inc. (NASDAQ:ARNA) by 7.0% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange ...
How Analysts Feel About Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)?  Press Telegraph
Arena Pharmaceuticals Incorporated (NASDAQ:ARNA) Sellers Covered 5.74% of ...  Consumer Eagle
Company Update (NASDAQ:ARNA): Arena Pharmaceuticals, Inc. and Eisai Inc ...
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) and Eisai Inc. announced that the Federal Commission for the Protection Against Sanitary Risk (COFEPRIS) has granted regulatory approval of the chronic weight management agent VENESPRI´┐Ż(lorcaserin HCl: ...
Arena Pharmaceuticals Inc. (NASDAQ:ARNA) Receives Consensus Rating of " ...  BBNS
Arena Pharmaceuticals boosted as obesity drug gets Mexican approval  Proactive Investors USA & Canada